Plus Therapeutics Inc
Taking a Closer Look At Plus Therapeutics Inc (PSTV) Following Its Recent Trade
Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...
Plus Therapeutics Inc (PSTV) receives a Buy rating from D. Boral Capital
Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...
Plus Therapeutics Inc (PSTV) rating upgrades by D. Boral Capital
In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
An Analysis of Plus Therapeutics Inc (PSTV)’s Potential Price Growth
In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
Investing in Plus Therapeutics Inc (PSTV): What You Must Know
Plus Therapeutics Inc’s filing revealed that its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for reported ...
Plus Therapeutics Inc’s latest rating changes from various analysts
In a filing, Plus Therapeutics Inc revealed its Chief Financial Officer Sims Andrew John Hugh MacIntyr acquired Company’s shares for ...
